細胞シグナリング市場、シェア、規模、動向、産業分析レポート：製品タイプ別、技術別、経路別、地域別、セグメント別予測、2024年～2032年

Polaris Market Research社の最新調査によると、世界の細胞シグナリング市場規模は2032年までに64億9,649万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

バイオ医薬品分野の拡大が細胞シグナリング市場の成長を促進しています。精密医療が普及するにつれ、洗練された細胞シグナリング伝達技術への需要が高まっています。これらのツールは、複雑な細胞経路を解読し、疾患解明や標的治療開発を支援するために不可欠です。モノクローナル抗体や細胞ベースの治療薬といった新規の生物製剤の出現は、高度な細胞シグナリング伝達製品の必要性をさらに高めています。

政府の資金援助や投資は、ライフサイエンス分野の研究や技術革新を支援することで、細胞シグナリング市場をさらに牽引しています。学術機関、研究機関、バイオテクノロジー企業に授与される助成金は、細胞コミュニケーション経路をターゲットとした画期的な研究や技術的進歩を推進します。政府のイニシアチブによって促進される共同努力は、学際的研究アプローチを強化し、治療開発を促進します。バイオテクノロジーパークや研究施設などのインフラへの投資は、技術革新と商業化を促進する環境を作り出します。規制の枠組みは、倫理的な研究慣行と製品の安全性を確保し、公衆衛生を守りつつ市場の状況を形成します。

個別化医療は、遺伝的体質など個人の特性に基づいて治療法を調整するもので、正確で低負荷の治療を行うために細胞シグナリング伝達経路に依存しています。細胞シグナリング伝達の極めて重要な役割は、細胞のコミュニケーションを制御し、細胞の反応や行動を形成することにあります。これらの経路を解読することは、病気のバイオマーカーや分子標的を特定するのに役立ち、正確な診断やオーダーメイドの治療を可能にします。ヘルスケアプロバイダーは個別化アプローチを優先し、患者はオーダーメイド治療を求めているため、細胞シグナリング伝達技術や標的治療薬への投資が増加しています。

アジア、ラテンアメリカ、アフリカなどの地域では慢性疾患の罹患率が上昇しており、細胞シグナリング伝達技術に大きく依存する高度な診断や治療に対する需要が高まっています。これらの市場の政府やヘルスケア当局も生物医学研究開発への投資を増やしており、技術革新と技術導入を促進しています。さらに、ヘルスケア資金と保険適用範囲の改善により、細胞シグナリング伝達に基づくものを含む先進医療へのアクセスが拡大しています。患者人口の増加と個別化医療に対する意識の高まりは、これらの地域における細胞シグナリング伝達製品およびサービスに対する需要を促進しています。

細胞シグナリング市場レポートハイライト

2023年、消耗品セグメントは、アッセイキットや試薬への高い需要、頻繁な再購入、研究ラボでの広範な採用により、大きな売上シェアを占めました。

2023年、内分泌シグナル分野は、幅広い適用性、ホルモン関連治療への高い需要により、大きな収益シェアを占めました。

2023年には、高解像度イメージングと創薬・薬剤開発における広範な応用により、顕微鏡分野が大きな収益シェアを占めました。

2023年、AKTシグナル伝達経路セグメントは、細胞の生存と増殖における中心的役割と幅広い臨床応用により、大きな収益シェアを占めました。

2023年、北米地域は、確立されたバイオ医薬品産業、高度なヘルスケアインフラ、規制当局の支援と資金調達により、世界市場を独占しました。

Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Promega Corporation, Qiagen N.V., SignalChem Pharmaceuticals Inc.

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の細胞シグナリング市場の洞察

• 細胞シグナリング-業界スナップショット
• 細胞シグナリング市場力学
  • 促進要因と機会
    • 調査活動の増加により、製品の需要が促進されると予測されます。
    • プロテオミクスとゲノミクスの進歩が細胞シグナリング市場の成長を促進すると期待されている
  • 抑制要因と課題
    • 調査コストが高い
• PESTLE分析
• 細胞シグナリング業界の動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 タイプ別の世界市場

• 主な調査結果
• イントロダクション
• オートクリンシグナル伝達
• 内分泌シグナル伝達
• 傍分泌シグナル伝達
• その他

第6章 経路別の世界市場

• 主な調査結果
• イントロダクション
• AMPKシグナル伝達経路
• AKTシグナル伝達経路
• ErbB/HERシグナル伝達経路
• その他

第7章 技術別の世界市場

• 主な調査結果
• イントロダクション
• ウエスタンブロッティング
• フローサイトメトリー
• 顕微鏡検査
• ELISA
• 質量分析
• その他

第8章 製品別の世界市場

• 主な調査結果
• イントロダクション
• 機器
• 消耗品

第9章 地域別の世界市場

• 主な調査結果
• イントロダクション
  • 細胞シグナリング市場の評価、地域別、2019-2032年
• 細胞シグナリング市場-北米
  • 北米：細胞シグナリング市場、タイプ別、2019-2032年
  • 北米：細胞シグナリング市場、製品別、2019-2032年
  • 北米：細胞シグナリング市場、経路別、2019年～2032年
  • 北米：細胞シグナリング市場、技術別、2019年～2032年
  • 細胞シグナリング市場-米国
  • 細胞シグナリング市場- カナダ
• 細胞シグナリング市場- 欧州
  • 欧州：細胞シグナリング市場、タイプ別、2019-2032年
  • 欧州：細胞シグナリング市場、製品別、2019-2032年
  • 欧州：細胞シグナリング市場、経路別、2019-2032年
  • 欧州：細胞シグナリング市場、技術別、2019-2032年
  • 細胞シグナリング市場- 英国
  • 細胞シグナリング市場- フランス
  • 細胞シグナリング市場- ドイツ
  • 細胞シグナリング市場- イタリア
  • 細胞シグナリング市場- スペイン
  • 細胞シグナリング市場- オランダ
  • 細胞シグナリング市場- ロシア
• 細胞シグナリング市場- アジア太平洋地域
  • アジア太平洋地域：細胞シグナリング市場、タイプ別、2019年～2032年
  • アジア太平洋地域：細胞シグナリング市場、製品別、2019年～2032年
  • アジア太平洋地域：細胞シグナリング伝達経路別市場、2019年～2032年
  • アジア太平洋地域：細胞シグナリング市場、技術別、2019-2032年
  • 細胞シグナリング市場- 中国
  • 細胞シグナリング市場- インド
  • 細胞シグナリング市場- 日本
  • 細胞シグナリング市場- マレーシア
  • 細胞シグナリング市場- インドネシア
  • 細胞シグナリング市場- 韓国
• 細胞シグナリング市場-中東およびアフリカ
  • 中東およびアフリカ：細胞シグナリング市場、タイプ別、2019-2032年
  • 中東およびアフリカ：細胞シグナリング市場、製品別、2019-2032年
  • 中東およびアフリカ：細胞シグナリング市場、経路別、2019-2032年
  • 中東およびアフリカ：細胞シグナリング市場、技術別、2019-2032年
  • 細胞シグナリング市場- サウジアラビア
  • 細胞シグナリング市場- 南アフリカ
  • 細胞シグナリング市場- イスラエル
  • 細胞シグナリング市場-UAE
• 細胞シグナリング市場-ラテンアメリカ
  • ラテンアメリカ：細胞シグナリング市場、タイプ別、2019-2032年
  • ラテンアメリカ：細胞シグナリング市場、製品別、2019-2032年
  • ラテンアメリカ：細胞シグナリング市場、経路別、2019年～2032年
  • ラテンアメリカ：細胞シグナリング市場、技術別、2019年～2032年
  • 細胞シグナリング市場- メキシコ
  • 細胞シグナリング市場- ブラジル
  • 細胞シグナリング市場- アルゼンチン

第10章 競合情勢

• 拡大と買収の分析
  • 拡大
  • 買収
• パートナーシップ/コラボレーション/契約/公開

第11章 会社のプロファイル

• Abcam plc
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Agilent Technologies, Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Becton, Dickinson and Company (BD)
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Bio-Rad Laboratories, Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Bio-Techne Corporation
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Cell Biolabs, Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Cell Signaling Technology, Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Danaher Corporation
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• GenScript Biotech Corporation
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Merck KGaA
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• PerkinElmer, Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Promega Corporation
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Qiagen N.V
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• SignalChem Pharmaceuticals Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発
• Thermo Fisher Scientific Inc.
  • 会社概要
  • 財務実績
  • 製品ベンチマーク
  • 最近の開発

List of Tables

• Table 1 Global Cell Signaling Market, by Type, by Region, 2019-2032 (USD Million)
• Table 2 Global Cell Signaling Market, by Pathway, by Region, 2019-2032 (USD Million)
• Table 3 Global Cell Signaling Market, by Technology, by Region, 2019-2032 (USD Million)
• Table 4 Global Cell Signaling Market, by Product, by Region, 2019-2032 (USD Million)
• Table 5 Cell Signaling Market Assessment, By Geography, 2019-2032 (USD Million)
• Table 6 North America: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 7 North America: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 8 North America: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 9 North America: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 10 U.S.: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 11 U.S.: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 12 U.S.: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 13 U.S.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 14 Canada: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 15 Canada: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 16 Canada: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 17 Canada: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 18 Europe: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 19 Europe: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 20 Europe: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 21 Europe: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 22 Germany: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 23 Germany: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 24 Germany: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 25 Germany: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 26 France: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 27 France: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 28 France: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 29 France: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 30 UK: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 31 UK: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 32 UK: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 33 UK: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 34 Italy: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 35 Italy: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 36 Italy: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 37 Italy: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 38 Netherlands: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 39 Netherlands: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 40 Netherlands: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 41 Netherlands: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 42 Spain: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 43 Spain: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 44 Spain: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 45 Spain: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 46 Russia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 47 Russia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 48 Russia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 49 Russia: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 50 Asia Pacific: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 51 Asia Pacific: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 52 Asia Pacific: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 53 Asia Pacific: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 54 China: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 55 China: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 56 China: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 57 China: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 58 Japan: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 59 Japan: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 60 Japan: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 61 Japan: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 62 India: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 63 India: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 64 India: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 65 India: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 66 Indonesia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 67 Indonesia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 68 Indonesia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 69 Indonesia: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 70 Malaysia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 71 Malaysia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 72 Malaysia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 73 Malaysia: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 74 South Korea: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 75 South Korea: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 76 South Korea: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 77 South Korea: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 78 Latin America: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 79 Latin America: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 80 Latin America: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 81 Latin America: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 82 Brazil: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 83 Brazil: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 84 Brazil: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 85 Brazil: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 86 Mexico: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 87 Mexico: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 88 Mexico: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 89 Mexico: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 90 Argentina: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 91 Argentina: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 92 Argentina: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 93 Argentina: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 94 Middle East & Africa: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 95 Middle East & Africa: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 96 Middle East & Africa: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 97 Middle East & Africa: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 98 UAE: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 99 UAE: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 100 UAE: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 101 UAE: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 102 Saudi Arabia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 103 Saudi Arabia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 104 Saudi Arabia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 105 Saudi Arabia: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 106 South Africa: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 107 South Africa: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 108 South Africa: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 109 South Africa: Cell Signaling Market, by Product, 2019-2032 (USD Million)
• Table 110 Israel: Cell Signaling Market, by Type, 2019-2032 (USD Million)
• Table 111 Israel: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• Table 112 Israel: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• Table 113 Israel: Cell Signaling Market, by Product, 2019-2032 (USD Million)

List of Figures

• Figure 1. Global Cell Signaling Market, 2019-2032 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Product
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Type
• Figure 7. Global Cell Signaling Market, by Type, 2021 & 2030 (USD Million)
• Figure 8. Market by Product
• Figure 9. Global Cell Signaling Market, by Product, 2021 & 2030 (USD Million)
• Figure 10. Market by Pathway
• Figure 11. Global Cell Signaling Market, by Pathway, 2021 & 2030 (USD Million)
• Figure 12. Market by Technology
• Figure 13. Global Cell Signaling Market, by Technology, 2021 & 2030 (USD Million)

The global cell signaling market size is expected to reach USD 6,496.49 Million by 2032, according to a new study by Polaris Market Research. The report "Cell Signaling Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Consumables); By Type; By Technology; By Pathway; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The expanding biopharmaceutical sector is propelling growth in the cell signaling market. As precision medicine gains traction, there's a heightened demand for sophisticated cell signaling technologies. These tools are essential for deciphering intricate cellular pathways, aiding in disease understanding, and targeted therapy development. The emergence of novel biologics, such as monoclonal antibodies and cell-based treatments, further increases the need for advanced cell signaling products.

Government funding and investments further drive the cell signaling market by supporting research and innovation in life sciences. Grants awarded to academic institutions, research organizations, and biotech companies drive groundbreaking studies and technological advancements targeting cellular communication pathways. Collaborative efforts fostered by government initiatives enhance interdisciplinary research approaches, facilitating therapeutic development. Investments in infrastructure, such as biotechnology parks and research facilities, create environments conducive to innovation and commercialization. Regulatory frameworks ensure ethical research practices and product safety, shaping the market landscape while safeguarding public health.

Personalized medicine tailors treatments based on individual characteristics such as genetic makeup, relying on cell signaling pathways for precise, low-impact therapies. Cell signaling's pivotal role lies in governing cell communication and shaping their responses and behaviors. Deciphering these pathways helps identify disease biomarkers and molecular targets, enabling accurate diagnostics and tailored treatments. With healthcare providers prioritizing personalized approaches and patients demanding tailored treatments, investments in cell signaling technologies and targeted therapeutics are increasing.

Rising incidences of chronic diseases in regions such as Asia, Latin America, and Africa are increasing the demand for advanced diagnostics and therapies, which heavily rely on cell signaling technologies. Governments and healthcare authorities in these markets are also investing more in biomedical research and development, fostering innovation and technology adoption. Moreover, improved healthcare funding and insurance coverage are expanding access to advanced medical treatments, including those based on cell signaling. The growing patient population and increasing awareness of personalized medicine are fueling demand for cell signaling products and services in these regions.

Cell Signaling Market Report Highlights

In 2023, the consumables segment held significant revenue share owing to high demand for assay kits and reagents, frequent repurchase, and widespread adoption in research labs.

In 2023, the endocrine signaling segment held significant revenue share owing to broad applicability, and high demand for hormone-related therapies.

In 2023, the microscopy segment held significant revenue share owing to high-resolution imaging, and wide application in drug discovery and development.

In 2023, the AKT signaling pathway segment held significant revenue share owing to central role in cell survival and proliferation, and wide clinical application.

In 2023, North America region dominated the global market due to established biopharmaceutical industry, advanced healthcare infrastructure, and regulatory support & funding.

The market is highly competitive owing to the existence of market players with a global presence, including Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Danaher Corporation, Merck KGaA, Promega Corporation, Qiagen N.V., SignalChem Pharmaceuticals Inc., and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Cell Signaling market report based on product, type, technology, pathway, and region:

Cell Signaling, Product Outlook (Revenue - USD Million, 2019 - 2032)

• Instruments
• Consumables

Cell Signaling, Type Outlook (Revenue - USD Million, 2019 - 2032)

• Autocrine Signaling
• Endocrine Signaling
• Paracrine Signaling
• Others

Cell Signaling, Technology Outlook (Revenue - USD Million, 2019 - 2032)

• Western Blotting
• Flow Cytometry
• Microscopy
• ELISA
• Mass Spectrometry
• Others

Cell Signaling, Pathway Outlook (Revenue - USD Million, 2019 - 2032)

• AMPK Signaling Pathway
• AKT Signaling Pathway
• ErbB/HER Signaling Pathway
• Others

Cell Signaling, Regional Outlook (Revenue - USD Million, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• France
• Germany
• UK
• Italy
• Netherlands
• Spain
• Russia
• Asia Pacific
• Japan
• China
• India
• Malaysia
• Indonesia
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Middle East & Africa
• Saudi Arabia
• UAE
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Cell Signaling Market Insights

• 4.1. Cell Signaling - Industry Snapshot
• 4.2. Cell Signaling Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing research activities are projected to spur the product demand
    • 4.2.1.2. Advancements in proteomics and genomics is expected to drive cell signaling market growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High cost of research
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTLE Analysis
• 4.5. Cell Signaling Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Cell Signaling Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cell Signaling Market, by Type, 2019-2032 (USD Million)
• 5.3. Autocrine Signaling
  • 5.3.1. Global Cell Signaling Market, by Autocrine Signaling, by Region, 2019-2032 (USD Million)
• 5.4. Endocrine Signaling
  • 5.4.1. Global Cell Signaling Market, by Endocrine Signaling, by Region, 2019-2032 (USD Million)
• 5.5. Paracrine Signaling
  • 5.5.1. Global Cell Signaling Market, by Paracrine Signaling, by Region, 2019-2032 (USD Million)
• 5.6. Others
  • 5.6.1. Global Cell Signaling Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Cell Signaling Market, by Pathway

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
• 6.3. AMPK Signaling Pathway
  • 6.3.1. Global Cell Signaling Market, by AMPK Signaling Pathway, by Region, 2019-2032 (USD Million)
• 6.4. AKT Signaling Pathway
  • 6.4.1. Global Cell Signaling Market, by AKT Signaling Pathway, by Region, 2019-2032 (USD Million)
• 6.5. ErbB/HER Signaling Pathway
  • 6.5.1. Global Cell Signaling Market, by ErbB/HER Signaling Pathway, by Region, 2019-2032 (USD Million)
• 6.6. Others
  • 6.6.1. Global Cell Signaling Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Cell Signaling Market, by Technology

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• 7.3. Western Blotting
  • 7.3.1. Global Cell Signaling Market, by Western Blotting, by Region, 2019-2032 (USD Million)
• 7.4. Flow Cytometry
  • 7.4.1. Global Cell Signaling Market, by Flow Cytometry, by Region, 2019-2032 (USD Million)
• 7.5. Microscopy
  • 7.5.1. Global Cell Signaling Market, by Microscopy, by Region, 2019-2032 (USD Million)
• 7.6. ELISA
  • 7.6.1. Global Cell Signaling Market, by ELISA, by Region, 2019-2032 (USD Million)
• 7.7. Mass Spectrometry
  • 7.7.1. Global Cell Signaling Market, by Mass Spectrometry, by Region, 2019-2032 (USD Million)
• 7.8. Others
  • 7.8.1. Global Cell Signaling Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Cell Signaling Market, by Product

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Cell Signaling Market, by Product, 2019-2032 (USD Million)
• 8.3. Instruments
  • 8.3.1. Global Cell Signaling Market, by Instruments, by Region, 2019-2032 (USD Million)
• 8.4. Consumables
  • 8.4.1. Global Cell Signaling Market, by Consumables, by Region, 2019-2032 (USD Million)

9. Global Cell Signaling Market, by Geography

• 9.1. Key findings
• 9.2. Introduction
  • 9.2.1. Cell Signaling Market Assessment, By Geography, 2019-2032 (USD Million)
• 9.3. Cell Signaling Market - North America
  • 9.3.1. North America: Cell Signaling Market, by Type, 2019-2032 (USD Million)
  • 9.3.2. North America: Cell Signaling Market, by Product, 2019-2032 (USD Million)
  • 9.3.3. North America: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
  • 9.3.4. North America: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.3.5. Cell Signaling Market - U.S.
    • 9.3.5.1. U.S.: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.3.5.2. U.S.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.3.5.3. U.S.: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.3.5.4. U.S.: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.3.6. Cell Signaling Market - Canada
    • 9.3.6.1. Canada: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.3.6.2. Canada: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.3.6.3. Canada: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.3.6.4. Canada: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• 9.4. Cell Signaling Market - Europe
  • 9.4.1. Europe: Cell Signaling Market, by Type, 2019-2032 (USD Million)
  • 9.4.2. Europe: Cell Signaling Market, by Product, 2019-2032 (USD Million)
  • 9.4.3. Europe: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
  • 9.4.4. Europe: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.5. Cell Signaling Market - UK
    • 9.4.5.1. UK: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.5.2. UK: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.5.3. UK: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.5.4. UK: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.6. Cell Signaling Market - France
    • 9.4.6.1. France: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.6.2. France: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.6.3. France: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.6.4. France: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.7. Cell Signaling Market - Germany
    • 9.4.7.1. Germany: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.7.2. Germany: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.7.3. Germany: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.7.4. Germany: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.8. Cell Signaling Market - Italy
    • 9.4.8.1. Italy: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.8.2. Italy: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.8.3. Italy: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.8.4. Italy: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.9. Cell Signaling Market - Spain
    • 9.4.9.1. Spain: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.9.2. Spain: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.9.3. Spain: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.9.4. Spain: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.10. Cell Signaling Market - Netherlands
    • 9.4.10.1. Netherlands: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.10.2. Netherlands: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.10.3. Netherlands: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.10.4. Netherlands: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.4.11. Cell Signaling Market - Russia
    • 9.4.11.1. Russia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.4.11.2. Russia.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.4.11.3. Russia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.4.11.4. Russia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• 9.5. Cell Signaling Market - Asia Pacific
  • 9.5.1. Asia Pacific: Cell Signaling Market, by Type, 2019-2032 (USD Million)
  • 9.5.2. Asia Pacific: Cell Signaling Market, by Product, 2019-2032 (USD Million)
  • 9.5.3. Asia Pacific: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
  • 9.5.4. Asia Pacific: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.5. Cell Signaling Market - China
    • 9.5.5.1. China: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.5.2. China.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.5.3. China: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.5.4. China: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.6. Cell Signaling Market - India
    • 9.5.6.1. India: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.6.2. India.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.6.3. India: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.6.4. India: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.7. Cell Signaling Market - Japan
    • 9.5.7.1. Japan: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.7.2. Japan.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.7.3. Japan: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.7.4. Japan: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.8. Cell Signaling Market - Malaysia
    • 9.5.8.1. Malaysia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.8.2. Malaysia.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.8.3. Malaysia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.8.4. Malaysia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.9. Cell Signaling Market - Indonesia
    • 9.5.9.1. Indonesia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.9.2. Indonesia.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.9.3. Indonesia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.9.4. Indonesia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.5.10. Cell Signaling Market - South Korea
    • 9.5.10.1. South Korea: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.5.10.2. South Korea.: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.5.10.3. South Korea: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.5.10.4. South Korea: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• 9.6. Cell Signaling Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Cell Signaling Market, by Type, 2019-2032 (USD Million)
  • 9.6.2. Middle East & Africa: Cell Signaling Market, by Product, 2019-2032 (USD Million)
  • 9.6.3. Middle East & Africa: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
  • 9.6.4. Middle East & Africa: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.6.5. Cell Signaling Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.6.5.2. Saudi Arabia: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.6.5.3. Saudi Arabia: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.6.5.4. Saudi Arabia: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.6.6. Cell Signaling Market - South Africa
    • 9.6.6.1. South Africa: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.6.6.2. South Africa: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.6.6.3. South Africa: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.6.6.4. South Africa: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.6.7. Cell Signaling Market - Israel
    • 9.6.7.1. Israel: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.6.7.2. Israel: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.6.7.3. Israel: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.6.7.4. Israel: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.6.8. Cell Signaling Market - UAE
    • 9.6.8.1. UAE: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.6.8.2. UAE: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.6.8.3. UAE: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.6.8.4. UAE: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
• 9.7. Cell Signaling Market - Latin America
  • 9.7.1. Latin America: Cell Signaling Market, by Type, 2019-2032 (USD Million)
  • 9.7.2. Latin America: Cell Signaling Market, by Product, 2019-2032 (USD Million)
  • 9.7.3. Latin America: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
  • 9.7.4. Latin America: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.7.5. Cell Signaling Market - Mexico
    • 9.7.5.1. Mexico: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.7.5.2. Mexico: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.7.5.3. Mexico: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.7.5.4. Mexico: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.7.6. Cell Signaling Market - Brazil
    • 9.7.6.1. Brazil: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.7.6.2. Brazil: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.7.6.3. Brazil: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.7.6.4. Brazil: Cell Signaling Market, by Technology, 2019-2032 (USD Million)
  • 9.7.7. Cell Signaling Market - Argentina
    • 9.7.7.1. Argentina: Cell Signaling Market, by Type, 2019-2032 (USD Million)
    • 9.7.7.2. Argentina: Cell Signaling Market, by Product, 2019-2032 (USD Million)
    • 9.7.7.3. Argentina: Cell Signaling Market, by Pathway, 2019-2032 (USD Million)
    • 9.7.7.4. Argentina: Cell Signaling Market, by Technology, 2019-2032 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Proflies

• 11.1. Abcam plc
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Agilent Technologies, Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Becton, Dickinson and Company (BD)
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bio-Rad Laboratories, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. Bio-Techne Corporation
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Cell Biolabs, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Cell Signaling Technology, Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Danaher Corporation
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. GenScript Biotech Corporation
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Merck KGaA
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. PerkinElmer, Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Promega Corporation
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Qiagen N.V
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. SignalChem Pharmaceuticals Inc.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development
• 11.15. Thermo Fisher Scientific Inc.
  • 11.15.1. Company Overview
  • 11.15.2. Financial Performance
  • 11.15.3. Product Benchmarking
  • 11.15.4. Recent Development